Literature DB >> 10580061

Generation of recombinant lentogenic Newcastle disease virus from cDNA.

Angela Römer-Oberdörfer1, Egbert Mundt1, Teshome Mebatsion2, Ursula J Buchholz1, Thomas C Mettenleiter1.   

Abstract

Recombinant lentogenic Newcastle disease virus (NDV) of the vaccine strain Clone-30 was reproducibly generated after simultaneous expression of antigenome-sense NDV RNA and NDV nucleoprotein, phosphoprotein and RNA-dependent RNA polymerase from plasmids transfected into cells stably expressing T7 RNA polymerase. For this purpose, the genome of Clone-30, comprising 15186 nt, was cloned and sequenced prior to assembly into a full-length cDNA clone under control of a T7 RNA polymerase promoter. Recombinant virus was amplified by inoculation of transfection supernatant into the allantoic cavity of embryonated specific-pathogen-free (SPF) chicken eggs. Two marker restriction sites comprising a total of five nucleotide changes artificially introduced into noncoding regions were present in the progeny virus. The recombinant NDV was indistinguishable from the parental wild-type virus with respect to its growth characteristics in cell culture and in embryonated eggs. Moreover, an intracerebral pathogenicity index of 0.29 was obtained for both viruses as determined by intracerebral inoculation of day-old SPF chickens, proving that the recombinant NDV is a faithful copy of the parental vaccine strain of NDV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580061     DOI: 10.1099/0022-1317-80-11-2987

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  50 in total

Review 1.  Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection.

Authors:  M Hatta; G Neumann; Y Kawaoka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

3.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Development of a reverse genetics system based on RNA polymerase II for Newcastle disease virus genotype VII.

Authors:  Jianzhong Wang; Chunfeng Wang; Na Feng; Hualei Wang; Xuexing Zheng; Songtao Yang; Yuwei Gao; Xianzhu Xia; Renfu Yin; Xiufan Liu; Shunlin Hu; Chan Ding; Shengqing Yu; Yanlong Cong; Zhuang Ding
Journal:  Virus Genes       Date:  2014-11-11       Impact factor: 2.332

5.  Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens.

Authors:  Madhuri Subbiah; Sunil K Khattar; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.

Authors:  Teshome Mebatsion; Marck J M Koolen; Leonie T C de Vaan; Niels de Haas; Marian Braber; Angela Römer-Oberdörfer; Paul van den Elzen; Pieter van der Marel
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus.

Authors:  Joyce Wong; Allison Schulman; Kaitlyn Kelly; Dmitriy Zamarin; Peter Palese; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

8.  Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein.

Authors:  Madhan Mohan Chellappa; Sohini Dey; Satish Gaikwad; Dinesh C Pathak; Vikram N Vakharia
Journal:  Virus Genes       Date:  2017-02-09       Impact factor: 2.332

9.  Identification of a mutation in editing of defective Newcastle disease virus recombinants that modulates P-gene mRNA editing and restores virus replication and pathogenicity in chicken embryos.

Authors:  Teshome Mebatsion; Leonie T C de Vaan; Niels de Haas; Angela Römer-Oberdörfer; Marian Braber
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Genomic comparison of the complete coding and intergenic regions of the VG/GA Newcastle disease virus and its respirotropic clone 5.

Authors:  Francisco Perozo; Pedro Villegas; Claudio L Afonso
Journal:  Virus Genes       Date:  2008-06-24       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.